Changeflow GovPing Pharma & Drug Safety Recombinant receptors binding B cell activation...
Routine Notice Added

Recombinant receptors binding B cell activation factor receptor patent

Email

Summary

Recombinant receptors binding B cell activation factor receptor patent

Source document (simplified)

← EPO Patent Bulletin

RECOMBINANT RECEPTORS BINDING B CELL ACTIVATION FACTOR RECEPTOR AND USES THEREOF

Publication EP4532534A1 Kind: A1 Mar 18, 2026

Applicants

Seattle Children's Hospital d/b/a Seattle
Children's Research Institute

Inventors

JENSEN, Michael C., JOHNSON, Adam, BAXTER, Blake

IPC Classifications

C07K 14/705 20060101AFI20260209BHEP A61K 35/17 20250101ALI20260209BHEP A61K 47/69 20170101ALI20260209BHEP A61P 35/00 20060101ALI20260209BHEP C12N 15/62 20060101ALI20260209BHEP C12N 15/85 20060101ALI20260209BHEP A61K 48/00 20060101ALI20260209BHEP C07K 16/28 20060101ALI20260209BHEP C12N 5/10 20060101ALI20260209BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.

Free. Unsubscribe anytime.